(PHLT) Performant Healthcare - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: (N/A)
PHLT EPS (Earnings per Share)
PHLT Revenue
PHLT: Audit, Recovery, Analytics, Claims, Reporting
Performant Healthcare, Inc. (NASDAQ:PHLT) is a specialized healthcare services company that leverages advanced technology, analytics, and proprietary data assets to help healthcare payers identify, prevent, and recover improper payments. By providing audit, recovery, and analytics services, the company supports its clients in mitigating financial losses due to waste and improper payments. Its service portfolio includes coordination-of-benefits services, claims-based services for auditing and identifying improperly paid claims, and advanced reporting capabilities to prevent future instances of improper payments.
The companys expertise in healthcare claims auditing and recovery is complemented by its support services, customer care, and stakeholder training programs, which equip clients with the tools and knowledge needed to minimize improper payments. Founded in 1976 and headquartered in Plantation, Florida, Performant Healthcare, Inc. has evolved significantly, having changed its name from Performant Financial Corporation to its current name in December 2024, reflecting its focused approach on the healthcare sector.
From a technical analysis perspective, PHLTs stock is currently trading at $2.58, slightly above its 20-day Simple Moving Average (SMA) of $2.42 but below its 50-day SMA of $2.61 and significantly below its 200-day SMA of $3.08. The Average True Range (ATR) indicates a recent volatility of 6.83%, suggesting moderate price movements. Given the stocks current position relative to its SMAs and considering the ATR, a potential trading strategy could involve monitoring for a breakout above the 50-day SMA or a drop below the 20-day SMA, as these could signal further directional movement.
Fundamentally, Performant Healthcare, Inc. has a market capitalization of $181.24M USD, and its negative Return on Equity (RoE) of -12.97% indicates that the company is currently not generating profits for its shareholders. The absence of P/E and forward P/E ratios further underscores the companys current unprofitability. However, investors should consider the potential for future profitability as the company continues to grow its services and improve operational efficiency.
Forecasting PHLTs stock performance involves integrating both technical and fundamental analyses. Given the current technical indicators and the fundamental data, a cautious outlook is warranted. If the company can demonstrate a path to profitability, potentially through expanding its client base or improving its operational efficiency, this could positively impact its stock price. Conversely, failure to address current unprofitability could lead to further declines. A breakout above the 50-day SMA could be an initial positive signal, while sustained trading below the 20-day SMA might indicate further downside risk. As such, investors should closely monitor both the companys financial performance and technical indicators for signs of a turnaround or further decline.
Additional Sources for PHLT Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
PHLT Stock Overview
Market Cap in USD | 181m |
Sector | Healthcare |
Industry | Health Information Services |
GiC Sub-Industry | Health Care Services |
IPO / Inception | 2012-08-10 |
PHLT Stock Ratings
Growth Rating | 38.2 |
Fundamental | -15.8 |
Dividend Rating | 0.0 |
Rel. Strength | 11.2 |
Analysts | 5 of 5 |
Fair Price Momentum | 3.43 USD |
Fair Price DCF | 1.14 USD |
PHLT Dividends
Currently no dividends paidPHLT Growth Ratios
Growth Correlation 3m | 15.6% |
Growth Correlation 12m | -52.3% |
Growth Correlation 5y | 45.4% |
CAGR 5y | 37.77% |
CAGR/Max DD 5y | 0.54 |
Sharpe Ratio 12m | -0.08 |
Alpha | 0.70 |
Beta | 0.104 |
Volatility | 63.58% |
Current Volume | 125.7k |
Average Volume 20d | 119.7k |
As of June 13, 2025, the stock is trading at USD 3.28 with a total of 125,740 shares traded.
Over the past week, the price has changed by +9.33%, over one month by +27.13%, over three months by +30.16% and over the past year by +5.81%.
Neither. Based on ValueRay´s Fundamental Analyses, Performant Healthcare is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -15.78 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of PHLT is around 3.43 USD . This means that PHLT is currently overvalued and has a potential downside of 4.57%.
Performant Healthcare has received a consensus analysts rating of 5.00. Therefor, it is recommend to buy PHLT.
- Strong Buy: 3
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, PHLT Performant Healthcare will be worth about 3.7 in June 2026. The stock is currently trading at 3.28. This means that the stock has a potential upside of +13.11%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 7 | 113.4% |
Analysts Target Price | 7 | 113.4% |
ValueRay Target Price | 3.7 | 13.1% |